A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive Bladder
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore additional benefit of solifenacin after 12-week
treatment, compared with alpha blocker monotherapy in men with residual OAB symptoms.